<DOC>
	<DOC>NCT02964208</DOC>
	<brief_summary>The AMPLATZER LAA Occluder is a transcatheter, self-expanding nitinol device intended for use in preventing thrombus embolization from the LAA. The purpose of this study is to compile real world outcome data on the use of AMPLATZER LAA Occluder in subjects with non-valvular atrial fibrillation (NVAF)</brief_summary>
	<brief_title>AMPLATZERâ„¢ LAA Occluder Post Approval Study (PAS)</brief_title>
	<detailed_description>The AMPLATZER LAA Occluder device will be clinically evaluated through this post approval study. This is a prospective, multicenter, non-randomized observational post-approval study, on patients who will undergo an implant of the AMPLATZER LAA Occluder.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>18 years of age or older Documented history of nonvalvular atrial fibrillation Subject intended to be implanted with an AMPLATZER LAA Occluder device Women of childbearing potential who are, or plan to become, pregnant during the time of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Thromboembolism</keyword>
	<keyword>Stroke</keyword>
	<keyword>ACP</keyword>
	<keyword>Left Atrial Appendage</keyword>
	<keyword>Cardiac Plug</keyword>
</DOC>